Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/103337
Título: | Urinary Mass Spectrometry Profiles in Age-Related Macular Degeneration | Autor: | Laíns, Inês Mendez, Kevin M Gil, João Q. Miller, John B Kelly, Rachel S Barreto, Patrícia Susana Correia Lopes Kim, Ivana K Vavvas, Demetrios G Murta, Joaquim N. Liang, Liming Silva, Rufino Miller, Joan W Lasky-Su, Jessica Husain, Deeba |
Palavras-chave: | age-related macular degeneration; metabolomics; urine | Data: | 11-Fev-2022 | Título da revista, periódico, livro ou evento: | Journal of Clinical Medicine | Volume: | 11 | Número: | 4 | Resumo: | We and others have shown that patients with different severity stages of age-related macular degeneration (AMD) have distinct plasma metabolomic profiles compared to controls. Urine is a biofluid that can be obtained non-invasively and, in other fields, urine metabolomics has been proposed as a feasible alternative to plasma biomarkers. However, no studies have applied urinary mass spectrometry (MS) metabolomics to AMD. This study aimed to assess urinary metabolomic profiles of patients with different stages of AMD and a control group. We included two prospectively designed, multicenter, cross-sectional study cohorts: Boston, US (n = 185) and Coimbra, Portugal (n = 299). We collected fasting urine samples, which were used for metabolomic profiling (Ultrahigh Performance Liquid chromatography-Mass Spectrometry). Multivariable logistic and ordinal logistic regression models were used for analysis, accounting for gender, age, body mass index and use of AREDS supplementation. Results from both cohorts were then meta-analyzed. No significant differences in urine metabolites were seen when comparing patients with AMD and controls. When disease severity was considered as an outcome, six urinary metabolites differed significantly (p < 0.01). In particular, two of the metabolites identified have been previously shown by our group to also differ in the plasma of patients of AMD compared to controls and across severity stages. While there are fewer urinary metabolites associated with AMD than plasma metabolites, this study identified some differences across stages of disease that support previous work performed with plasma, thus highlighting the potential of these metabolites as future biomarkers for AMD. | URI: | https://hdl.handle.net/10316/103337 | ISSN: | 2077-0383 | DOI: | 10.3390/jcm11040940 | Direitos: | openAccess |
Aparece nas coleções: | FMUC Medicina - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Urinary-Mass-Spectrometry-Profiles-in-AgeRelated-Macular-DegenerationJournal-of-Clinical-Medicine.pdf | 273.24 kB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
3
Visto em 7/out/2024
Citações WEB OF SCIENCETM
3
Visto em 2/out/2024
Visualizações de página
115
Visto em 15/out/2024
Downloads
51
Visto em 15/out/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons